{"id":"https://openalex.org/W7214770490","doi":"https://doi.org/10.7759/cureus.117154","title":"Chronic Myeloid Leukemia Progressing to Early T-Cell Precursor Lymphoblastic Blast Phase Following Treatment Default: An Integrated Morphologic, Immunophenotypic, Cytogenetic, and Molecular Case Report","display_name":"Chronic Myeloid Leukemia Progressing to Early T-Cell Precursor Lymphoblastic Blast Phase Following Treatment Default: An Integrated Morphologic, Immunophenotypic, Cytogenetic, and Molecular Case Report","publication_year":2026,"publication_date":"2026-09-29","ids":{"openalex":"https://openalex.org/W7214770490","doi":"https://doi.org/10.7759/cureus.117154","pmid":"https://pubmed.ncbi.nlm.nih.gov/42960313","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13718997"},"language":"en","primary_location":{"id":"doi:10.7759/cureus.117154","doi":"https://doi.org/10.7759/cureus.117154","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117154","pdf_url":"https://www.cureus.com/articles/532491-chronic-myeloid-leukemia-progressing-to-early-t-cell-precursor-lymphoblastic-blast-phase-following-treatment-default-an-integrated-morphologic-immunophenotypic-cytogenetic-and-molecular-case-report.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.cureus.com/articles/532491-chronic-myeloid-leukemia-progressing-to-early-t-cell-precursor-lymphoblastic-blast-phase-following-treatment-default-an-integrated-morphologic-immunophenotypic-cytogenetic-and-molecular-case-report.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045299051","display_name":"Sushma Cherukuru","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Sushma Cherukuru","raw_affiliation_strings":["Pathology, American Institute of Pathology and Laboratory Sciences Pvt. Ltd. (AMPATH), Hyderabad, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology, American Institute of Pathology and Laboratory Sciences Pvt. Ltd. (AMPATH), Hyderabad, IND","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153455612","display_name":"Surya Prakashrao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Surya Prakashrao","raw_affiliation_strings":["Cytogenetics, American Institute of Pathology and Laboratory Sciences Pvt. Ltd. (AMPATH), Hyderabad, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cytogenetics, American Institute of Pathology and Laboratory Sciences Pvt. Ltd. (AMPATH), Hyderabad, IND","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153443069","display_name":"Sachin J","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4399598429","display_name":"Citizens Specialty Hospitals","ror":"https://ror.org/00v3dp115","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4399598429"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sachin J","raw_affiliation_strings":["Hematology, Citizens Specialty Hospitals, Hyderabad, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, Citizens Specialty Hospitals, Hyderabad, IND","institution_ids":["https://openalex.org/I4399598429"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125557287","display_name":"Mukkanteswararao Kasaragadda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mukkanteswararao Kasaragadda","raw_affiliation_strings":["Genetics, American Institute of Pathology and Laboratory Sciences Pvt. Ltd. (AMPATH), Hyderabad, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genetics, American Institute of Pathology and Laboratory Sciences Pvt. Ltd. (AMPATH), Hyderabad, IND","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050251916","display_name":"SambasivaRao Patibandla","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sambasivarao Patibandla","raw_affiliation_strings":["Genetics, American Institute of Pathology and Laboratory Sciences Pvt. Ltd. (AMPATH), Hyderabad, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genetics, American Institute of Pathology and Laboratory Sciences Pvt. Ltd. (AMPATH), Hyderabad, IND","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153405044","display_name":"Kiran K","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kiran K","raw_affiliation_strings":["Genetics, American Institute of Pathology and Laboratory Sciences Pvt. Ltd. (AMPATH), Hyderabad, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genetics, American Institute of Pathology and Laboratory Sciences Pvt. Ltd. (AMPATH), Hyderabad, IND","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5153485695","display_name":"Shalini Singh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shalini Singh","raw_affiliation_strings":["Genetics, American Institute of Pathology and Laboratory Sciences Pvt. Ltd. (AMPATH), Hyderabad, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genetics, American Institute of Pathology and Laboratory Sciences Pvt. Ltd. (AMPATH), Hyderabad, IND","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5045299051"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.68079149,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"9","first_page":"e117154","last_page":"e117154"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.007300000172108412,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/early-t-cell-precursor-acute-lymphoblastic-leukemia","display_name":"early T-cell precursor acute lymphoblastic leukemia","score":0.9269999861717224},{"id":"https://openalex.org/keywords/treatment-default","display_name":"treatment default","score":0.6430000066757202},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.921999990940094},{"id":"https://openalex.org/keywords/philadelphia-chromosome","display_name":"Philadelphia chromosome","score":0.8889999985694885},{"id":"https://openalex.org/keywords/trisomy-8","display_name":"trisomy 8","score":0.9559999704360962},{"id":"https://openalex.org/keywords/del-7q","display_name":"del(7q)","score":0.9570000171661377},{"id":"https://openalex.org/keywords/immunophenotyping","display_name":"immunophenotyping","score":0.6019999980926514},{"id":"https://openalex.org/keywords/chromosomal-abnormalities","display_name":"chromosomal abnormalities","score":0.5759999752044678},{"id":"https://openalex.org/keywords/bcr-abl1","display_name":"BCR-ABL1","score":0.6759999990463257},{"id":"https://openalex.org/keywords/cd7","display_name":"CD7","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9526000022888184},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5669999718666077},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5372999906539917},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.4832000136375427},{"id":"https://openalex.org/C124964019","wikidata":"https://www.wikidata.org/wiki/Q11616062","display_name":"Precursor cell","level":3,"score":0.4203999936580658},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.361299991607666},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34209999442100525},{"id":"https://openalex.org/C2909145159","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Blast Crisis","level":3,"score":0.32429999113082886},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.3003000020980835},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.2872999906539917},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.2578999996185303}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.7759/cureus.117154","doi":"https://doi.org/10.7759/cureus.117154","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117154","pdf_url":"https://www.cureus.com/articles/532491-chronic-myeloid-leukemia-progressing-to-early-t-cell-precursor-lymphoblastic-blast-phase-following-treatment-default-an-integrated-morphologic-immunophenotypic-cytogenetic-and-molecular-case-report.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13718997","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13718997/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13718997/pdf/cureus-0018-00000117154.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Text"},{"id":"pmid:42960313","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42960313","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.7759/cureus.117154","doi":"https://doi.org/10.7759/cureus.117154","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117154","pdf_url":"https://www.cureus.com/articles/532491-chronic-myeloid-leukemia-progressing-to-early-t-cell-precursor-lymphoblastic-blast-phase-following-treatment-default-an-integrated-morphologic-immunophenotypic-cytogenetic-and-molecular-case-report.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214770490.pdf","grobid_xml":"https://content.openalex.org/works/W7214770490.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W292507057","https://openalex.org/W1968747503","https://openalex.org/W1974903585","https://openalex.org/W2006662570","https://openalex.org/W2007101568","https://openalex.org/W2033661259","https://openalex.org/W2052779132","https://openalex.org/W2058576674","https://openalex.org/W2082196918","https://openalex.org/W2166306614","https://openalex.org/W2514094904","https://openalex.org/W3009751715","https://openalex.org/W3131552388","https://openalex.org/W4307773592","https://openalex.org/W4318220699","https://openalex.org/W4389477845","https://openalex.org/W4389489165","https://openalex.org/W4402326607","https://openalex.org/W4410390359"],"related_works":["https://openalex.org/W4402326607","https://openalex.org/W3208487996","https://openalex.org/W2668112372","https://openalex.org/W4308649043","https://openalex.org/W2810426755","https://openalex.org/W7108474683","https://openalex.org/W4213329528","https://openalex.org/W4385693907","https://openalex.org/W7171614417","https://openalex.org/W2900595140"],"abstract_inverted_index":{"Chronic":[0],"myeloid":[1,7,47,90],"leukemia":[2,62,281],"(CML)":[3],"is":[4,55,282],"a":[5,98,112,228,285],"BCR::ABL1-positive":[6],"neoplasm":[8,68],"characterized":[9,69],"by":[10,70],"the":[11,204,207,242,262,266],"Philadelphia":[12,208],"chromosome":[13,209],"resulting":[14],"from":[15],"t(9;22)(q34;q11.2).":[16],"Although":[17],"tyrosine":[18],"kinase":[19],"inhibitors":[20],"(TKIs)":[21],"have":[22],"substantially":[23],"improved":[24],"outcomes":[25],"in":[26,103,284],"chronic-phase":[27],"CML,":[28],"progression":[29],"to":[30,110],"blast":[31,118,149,233],"phase":[32,234],"remains":[33],"an":[34,65,147,219,236,245,278],"important":[35],"feature":[36],"of":[37,42,72,81,89,101,154,174,206,231,244,264],"advanced":[38],"disease.":[39],"The":[40,133,157,192,259],"majority":[41],"CML":[43,102,232],"blast-phase":[44],"cases":[45],"demonstrate":[46],"or":[48,78,91],"precursor":[49,59],"B-cell":[50],"differentiation,":[51],"whereas":[52],"T-lineage":[53,67],"transformation":[54],"uncommon.":[56],"Early":[57],"T-cell":[58,84,280],"acute":[60],"lymphoblastic":[61,238],"(ETP-ALL)":[63],"represents":[64,227],"immature":[66,279],"expression":[71,80,88,173],"cytoplasmic":[73,163],"CD3":[74],"and":[75,86,108,127,140,169,176,190,214,240,250,257,274],"CD7,":[76,167],"weak":[77],"absent":[79],"conventional":[82],"mature":[83],"antigens,":[85],"frequent":[87,113],"stem-cell-associated":[92],"markers.":[93],"A":[94],"35-year-old":[95],"man":[96],"with":[97,117,129,137,171,197,211,235,269,287],"known":[99],"diagnosis":[100],"chronic":[104],"phase,":[105],"receiving":[106],"dasatinib":[107],"reported":[109],"be":[111],"treatment":[114],"defaulter,":[115],"presented":[116],"transformation.":[119],"Peripheral":[120],"blood":[121],"examination":[122],"demonstrated":[123,201],"marked":[124],"leukocytosis,":[125],"anemia,":[126],"thrombocytopenia,":[128],"64%":[130],"circulating":[131],"blasts.":[132],"blasts":[134,158],"were":[135,179],"large,":[136],"scant":[138],"cytoplasm":[139],"pleomorphic":[141],"nuclei.":[142],"Flow":[143],"cytometric":[144],"immunophenotyping":[145],"identified":[146,283],"abnormal":[148],"population":[150],"comprising":[151],"approximately":[152],"82%":[153],"viable":[155],"events.":[156],"expressed":[159],"CD34,":[160],"HLA-DR,":[161],"CD123,":[162],"CD3,":[164,183],"CD5":[165],"(dim),":[166],"CD13,":[168],"CD33,":[170],"variable":[172],"CD117":[175],"CD56.":[177],"They":[178],"negative":[180],"for":[181],"surface":[182],"CD1a,":[184],"CD4,":[185],"CD8,":[186],"B-lineage":[187],"markers,":[188],"TCR-\u03b3\u03b4,":[189],"myeloperoxidase.":[191],"overall":[193],"immunophenotype":[194],"was":[195],"consistent":[196],"ETP-ALL.":[198],"Cytogenetic":[199],"analysis":[200,217],"47,XY,del(7)(q21),+8,t(9;22)(q34;q11.2),":[202],"indicating":[203],"presence":[205],"together":[210],"trisomy":[212,255],"8":[213,256],"del(7q).":[215,258],"Molecular":[216],"detected":[218],"ABL1":[220,246],"p.Phe317Leu":[221],"(F317L)":[222],"kinase-domain":[223,248],"mutation.":[224],"This":[225],"case":[226,260],"rare":[229],"instance":[230],"ETP":[237],"phenotype":[239],"demonstrates":[241],"coexistence":[243],"F317L":[247],"mutation":[249],"additional":[251],"cytogenetic":[252],"abnormalities,":[253],"including":[254],"emphasizes":[261],"importance":[263],"integrating":[265],"clinical":[267],"history":[268],"morphologic,":[270],"flow":[271],"cytometric,":[272],"cytogenetic,":[273],"molecular":[275],"findings":[276],"when":[277],"patient":[286],"established":[288],"CML.":[289]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-09-30T00:00:00"}
